These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

454 related articles for article (PubMed ID: 27044334)

  • 1. Toll like receptor 9 antagonism modulates spinal cord neuronal function and survival: Direct versus astrocyte-mediated mechanisms.
    Acioglu C; Mirabelli E; Baykal AT; Ni L; Ratnayake A; Heary RF; Elkabes S
    Brain Behav Immun; 2016 Aug; 56():310-24. PubMed ID: 27044334
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Toll-like receptor 9 antagonism modulates astrocyte function and preserves proximal axons following spinal cord injury.
    Li L; Ni L; Eugenin EA; Heary RF; Elkabes S
    Brain Behav Immun; 2019 Aug; 80():328-343. PubMed ID: 30953770
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A toll-like receptor 9 antagonist reduces pain hypersensitivity and the inflammatory response in spinal cord injury.
    David BT; Ratnayake A; Amarante MA; Reddy NP; Dong W; Sampath S; Heary RF; Elkabes S
    Neurobiol Dis; 2013 Jun; 54():194-205. PubMed ID: 23313320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Astroglial TLR9 antagonism promotes chemotaxis and alternative activation of macrophages via modulation of astrocyte-derived signals: implications for spinal cord injury.
    Li L; Ni L; Heary RF; Elkabes S
    J Neuroinflammation; 2020 Feb; 17(1):73. PubMed ID: 32098620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A toll-like receptor 9 antagonist restores below-level glial glutamate transporter expression in the dorsal horn following spinal cord injury.
    Pallottie A; Ratnayake A; Ni L; Acioglu C; Li L; Mirabelli E; Heary RF; Elkabes S
    Sci Rep; 2018 Jun; 8(1):8723. PubMed ID: 29880832
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions between TLR7 and TLR9 agonists and receptors regulate innate immune responses by astrocytes and microglia.
    Butchi NB; Du M; Peterson KE
    Glia; 2010 Apr; 58(6):650-64. PubMed ID: 19998480
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A toll-like receptor 9 antagonist improves bladder function and white matter sparing in spinal cord injury.
    David BT; Sampath S; Dong W; Heiman A; Rella CE; Elkabes S; Heary RF
    J Neurotrauma; 2014 Nov; 31(21):1800-6. PubMed ID: 24936867
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TLR9 ligand, CpG-ODN, induces protection against cerebral ischemia/reperfusion injury via activation of PI3K/Akt signaling.
    Lu C; Ha T; Wang X; Liu L; Zhang X; Kimbrough EO; Sha Z; Guan M; Schweitzer J; Kalbfleisch J; Williams D; Li C
    J Am Heart Assoc; 2014 Apr; 3(2):e000629. PubMed ID: 24721797
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunostimulatory Activities of CpG-Oligodeoxynucleotides in Teleosts: Toll-Like Receptors 9 and 21.
    Lai CY; Yu GY; Luo Y; Xiang R; Chuang TH
    Front Immunol; 2019; 10():179. PubMed ID: 30800129
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytidine-phosphate-guanosine oligonucleotides induce interleukin-8 production through activation of TLR9, MyD88, NF-κB, and ERK pathways in odontoblast cells.
    He W; Zhang Y; Zhang J; Yu Q; Wang P; Wang Z; Smith AJ
    J Endod; 2012 Jun; 38(6):780-5. PubMed ID: 22595112
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Differential contribution of osteoclast- and osteoblast-lineage cells to CpG-oligodeoxynucleotide (CpG-ODN) modulation of osteoclastogenesis.
    Amcheslavsky A; Hemmi H; Akira S; Bar-Shavit Z
    J Bone Miner Res; 2005 Sep; 20(9):1692-9. PubMed ID: 16059640
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CpG-ODN exerts a neuroprotective effect via the TLR9/pAMPK signaling pathway by activation of autophagy in a neonatal HIE rat model.
    Ye L; Feng Z; Doycheva D; Malaguit J; Dixon B; Xu N; Zhang JH; Tang J
    Exp Neurol; 2018 Mar; 301(Pt A):70-80. PubMed ID: 29274721
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The TLR9 Antagonist iCpG-ODN at Different Dosages Inhibits Cerebral Ischemia/Reperfusion Injury in Mice.
    Zhou Y; Pan J; Peng Q; Dong Z; Deng L; Wang Y
    CNS Neurol Disord Drug Targets; 2017; 16(5):624-633. PubMed ID: 28176622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. CpG-oligodeoxynucleotide-induced TLR9 activation regulates macrophage TREM-1 expression and shedding.
    Molad Y; Pokroy-Shapira E; Carmon V
    Innate Immun; 2013 Dec; 19(6):623-30. PubMed ID: 23475790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cross-talk between toll-like receptors 5 and 9 on activation of human immune responses.
    Merlo A; Calcaterra C; Mènard S; Balsari A
    J Leukoc Biol; 2007 Sep; 82(3):509-18. PubMed ID: 17586660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Endogenous Expression of ODN-Related Peptides in Astrocytes Contributes to Cell Protection Against Oxidative Stress: Astrocyte-Neuron Crosstalk Relevance for Neuronal Survival.
    Ghouili I; Bahdoudi S; Morin F; Amri F; Hamdi Y; Coly PM; Walet-Balieu ML; Leprince J; Zekri S; Vaudry H; Vaudry D; Castel H; Amri M; Tonon MC; Masmoudi-Kouki O
    Mol Neurobiol; 2018 Jun; 55(6):4596-4611. PubMed ID: 28698967
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Oligodeoxynucleotides lacking CpG dinucleotides mediate Toll-like receptor 9 dependent T helper type 2 biased immune stimulation.
    Vollmer J; Weeratna RD; Jurk M; Samulowitz U; McCluskie MJ; Payette P; Davis HL; Schetter C; Krieg AM
    Immunology; 2004 Oct; 113(2):212-23. PubMed ID: 15379982
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A novel antagonist of TLR9 blocking all classes of immunostimulatory CpG-ODNs.
    Li Y; Cao H; Wang N; Xiang Y; Lu Y; Zhao K; Zheng J; Zhou H
    Vaccine; 2011 Mar; 29(11):2193-8. PubMed ID: 21036131
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADP-Ribosylation Factor 3 Mediates Cytidine-Phosphate-Guanosine Oligodeoxynucleotide-Induced Responses by Regulating Toll-Like Receptor 9 Trafficking.
    Wu JY; Kuo CC
    J Innate Immun; 2015; 7(6):623-36. PubMed ID: 26067373
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fingolimod may support neuroprotection via blockade of astrocyte nitric oxide.
    Colombo E; Di Dario M; Capitolo E; Chaabane L; Newcombe J; Martino G; Farina C
    Ann Neurol; 2014 Sep; 76(3):325-37. PubMed ID: 25043204
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.